Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for older heart patients.

A team of researchers, led by one of Indian origin, has found that a drug recently approved by the US Food and Drug ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

While proposing on Valentine’s Day can be very romantic, getting married can also be good for your heart because married men ...

Study led by Mount Sinai researcher shows sotagliflozin is the only drug in its class to demonstrate these results ...

The most common formulation of birth control pills has been linked to a doubling of relative risk of heart attack and stroke, ...

A simple scoring system could revolutionize how doctors prevent heart attacks and strokes by identifying patients most likely ...

Cardiologists believe Ozempic and Wegovy could help prevent heart disease. Dr. Marc Gibber, medical director and chief of cardiothoracic surgery at Baptist Health Bethesda Hospital East, stopped by ...

The most common formulation of birth control pills has been linked to a doubling of relative risk of heart attack an ...